ENG
  • KOR
  • ENG
An Open-label, Dose-escalation, Phase 1 Trial to Investigate the Safety, Tolerability, and Efficacy after Single- and Multiple-dose Administration of CT303 in Patients with Moderate to Severe Plaque Psoriasis
Seoul National University Hospital

Seoul National University Hospital

Seoul, Republic of Korea

Principal Investigator: Seong Jin Jo, M.D.

Pusan National University Hospital

Pusan National University Hospital

Pusan, Republic of Korea

Principal Investigator: Byung Soo Kim, M.D.

Cha University Bundang Medical Center

CHA Bundang Medical center, CHA University

Gyeonggi-do, Republic of Korea

Principal Investigator: Dong Hyun Kim, M.D.

A Multi-center, Open-label Dose-escalation and Dose-finding Phase I Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients with Acute Respiratory Distress Syndrome
Seoul National university Bundang Hospital

Seoul National University Bundang Hospital

Gyeonggi-do, Republic of Korea

Principal Investigator: Young Jae Cho, M.D.

Seoul National University Hospital

Seoul National University Hospital

Seoul, Republic of Korea

Principal Investigator: Jin Woo Lee, M.D.

SMG-SNU Boramae Medical Center

Seoul National University Boramae Medical Center

Seoul, Republic of Korea

Principal Investigator: Tae Yun Park, M.D.

Efficacy and Safety of Immune cell Therapy Group and Non-treatment
Group in Hepatocelluar Carcinoma Patients
Go to Phase Ⅲ
Seoul National University Hospital

Seoul National University Hospital

Seoul, Republic of Korea

Principal Investigator: Jung Hwan Yoon, MD

Samsung Medical Center

Samsung Medical Center

Seoul, Republic of Korea

Seoul Asan Medical Center

Seoul Asan Medical Center

Seoul, Republic of Korea

Korea University Ansan Hospital

Korea University Ansan Hospital

Gyeonggi-do, Republic of Korea

Korea University Guro Hospital

Korea University Guro Hospital

Seoul, Republic of Korea

Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment
Group in Hepatocellular Carcinoma Patients
Go to Phase Ⅳ
Seoul National University Hospital

Seoul National University Hospital

Seoul, Republic of Korea

Principal Investigator: Jung Hwan Yoon, MD

Samsung Medical Center

Samsung Medical Center

Seoul, Republic of Korea

Seoul Asan Medical Center

Seoul Asan Medical Center

Seoul, Republic of Korea

Korea University Ansan Hospital

Korea University Ansan Hospital

Gyeonggi-do, Republic of Korea

Korea University Guro Hospital

Korea University Guro Hospital

Seoul, Republic of Korea

Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group'
With Nexavar in Advanced HCC Patients
Go to Phase Ⅱ
Korea University Anam Hospital

Korea University Anam Hospital

Seoul, Republic of Korea

Principal Investigator: Soon Ho Um, MD, PhD

The Catholic University of Korea, Seoul ST. Mary's Hospital

The Catholic University of Korea, Seoul ST. Mary's Hospital

Seoul, Republic of Korea

Yonsei University Health System

Yonsei University Health System

Seoul, Republic of Korea

Inha University Hospital

Inha University Hospital

Incheon, Republic of Korea

Clinical Trial to Evaluate the Efficacy and Safety of "Immuncell-LC" in the Patients
Undergone TACE for Intermediate Stage Hepatocellular Carcinoma
Go to Phase Ⅱ
Seoul National University Hospital

Seoul National University Hospital

Seoul, Republic of Korea

Principal Investigator: Jung Hwan Yoon, MD

The Catholic University of Korea, Seoul ST. Mary's Hospital

The Catholic University of Korea, Seoul ST. Mary's Hospital

Seoul, Republic of Korea

Yonsei University Severance Hospital

Yonsei University Severance Hospital

Seoul, Republic of Korea

Evaluate the Efficacy and Safety of ‘Immuncell-LC’ in Patients Undergoing Liver Transplantation
Go to Phase Ⅱ
Seoul National University Hospital

Seoul National University Hospital

Seoul, Republic of Korea

Samsung Medical Center

Samsung Medical Center

Seoul, Republic of Korea

Clinical Trial to Assess the Efficacy and Safety of ‘INNOCELL Immuncell-LC’ With Temozolomide in Newly Diagnosed Glioblastoma of Korea
Go to Phase Ⅲ
Hanyang University Guri Hospital

Hanyang University Guri Hospital

Gyeonggi-do, Republic of Korea

Principal Investigator: Chunghyun Kim, MD

Seoul Asan Medical Center

Seoul Asan Medical Center

Seoul, Republic of Korea

Samsung Medical Center

Samsung Medical Center

Seoul, Republic of Korea

Yonsei University Health System

Yonsei University Health System

Seoul, Republic of Korea

Konkuk University Medical Center

Konkuk University Medical Center

Seoul, Republic of Korea

Kyung Hee University
Healthcare System

Kyung Hee University Healthcare System

Seoul, Republic of Korea

Korea University Anam Hospital

Korea University Anam Hospital

Seoul, Republic of Korea

A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
Pilot Study
Seoul National University Hospital

Seoul National University Hospital

Seoul, Republic of Korea

Principal Investigator: Hee Young Shin, MD, Ph.D

Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy
in Advanced Pancreatic Cancer
Go to Phase Ⅱ
Yonsei University Health System

Yonsei University Health System

Seoul, Republic of Korea

Principal Investigator: Si yong Song, MD, PhD

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
Go to Phase Ⅲ
Seoul National University Hospital

Seoul National University Hospital

Seoul, Republic of Korea

Yonsei University Severance Hospital

Yonsei University Severance Hospital

Seoul, Republic of Korea

Samsung Medical Center

Samsung Medical Center

Seoul, Republic of Korea

National Cancer Center

National Cancer Center

Gyeonggi-do, Republic of Korea

The Catholic University of Korea, Seoul ST. Mary's Hospital

The Catholic University of Korea, Seoul ST. Mary's Hospital

Seoul, Republic of Korea

Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer
Go to Phase Ⅱa
Gangnam Severance Hospital

Gangnam Severance Hospital

Seoul, Republic of Korea